Tetrahydrocannabinol (THC) antibody and antigen (hapten, BSA/OVA conjugated)

 Download 

Diagnostic anti-Tetrahydrocannabinol (THC) antibodies (anti-Tetrahydrocannabinol, anti-THC) and diagnostic hapten-carrier conjugates BSA-Tetrahydrocannabinol (THC), OVA-Tetrahydrocannabinol (THC), KLH-Tetrahydrocannabinol (THC) antigens for Pain THC detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Go to Pain diagnostics products collection>>

Product information

Size： 1mg | 10mg | 100mg

Product Description

BSA-Tetrahydrocannabinol (THC)

OVA-Tetrahydrocannabinol (THC)

Anti-human Tetrahydrocannabinol (THC) mouse monoclonal antibody (mAb)

Anti-human Tetrahydrocannabinol (THC) human monoclonal antibody (mAb)

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

1. Understanding Tetrahydrocannabinol (THC) in the Context of In Vitro Diagnosis (IVD)

Tetrahydrocannabinol (THC), the principal psychoactive component of cannabis, holds a prominent position in the landscape of in vitro diagnosis (IVD) due to its widespread use and physiological effects. In the realm of IVD, THC assumes a multifaceted role as a crucial target for detection and quantification in various biological samples, ranging from blood and urine to saliva and hair follicles. Understanding the intricate relationship between THC and IVD necessitates a comprehensive exploration of its biochemical properties, clinical implications, and the diverse applications of THC measurement in healthcare, forensic science, workplace safety, research, and public health initiatives.

2. Exploring the Role of Tetrahydrocannabinol in IVD

The pivotal role of Tetrahydrocannabinol in IVD is exemplified through a myriad of diagnostic assays that leverage advanced technologies and specialized reagents to detect and quantify THC levels with unparalleled precision. These assays encompass a spectrum of methodologies, including enzyme-linked immunosorbent assay (ELISA), liquid chromatography-mass spectrometry (LC-MS), gas chromatography-mass spectrometry (GC-MS), and immunoassays utilizing Carrier-coupled antigen, immunogen, hapten-carrier conjugates, BSA-conjugated, and OVA-conjugated antigens. By harnessing the specificity of THC antibodies and competitive antigens, these assays enable the accurate determination of THC concentration, facilitating clinical decision-making, forensic investigations, workplace drug testing, research endeavors, and public health interventions related to cannabis use and abuse.

3. Addressing the Need for THC Measurement

The imperative for measuring Tetrahydrocannabinol transcends disciplinary boundaries, encompassing various domains:

Clinical Diagnosis: THC measurement plays a pivotal role in diagnosing and monitoring individuals affected by cannabis-related disorders, providing valuable insights into the extent of THC exposure and its correlation with clinical manifestations. Healthcare professionals rely on accurate THC quantification to assess patient health status, guide treatment strategies, and evaluate the efficacy of interventions aimed at mitigating the adverse effects of cannabis use.

Forensic Analysis: In forensic science, THC measurement serves as a cornerstone in the investigation of drug-related crimes, accidents, and incidents. Law enforcement agencies leverage THC quantification data to establish patterns of drug usage, ascertain impairment levels, and corroborate evidence in legal proceedings. The forensic analysis of THC levels in biological specimens such as blood, urine, and hair samples offers critical information concerning an individual's recent or chronic cannabis use, aiding in the administration of justice and ensuring public safety.

Workplace Safety: In occupational settings, THC measurement is integral to maintaining workplace safety and productivity. Many industries implement drug testing programs to identify employees who may pose a risk due to impaired cognitive function or compromised motor skills resulting from cannabis consumption. By incorporating THC measurement into workplace drug testing protocols, employers can safeguard the well-being of employees, minimize the incidence of workplace accidents, and uphold organizational integrity.

Research and Public Health: THC measurement serves as a cornerstone in scientific research aimed at elucidating the pharmacokinetics, pharmacodynamics, and therapeutic potential of cannabinoids. Researchers leverage THC quantification data to investigate the impact of cannabis use on human physiology, neurobiology, and mental health outcomes. Furthermore, THC measurement informs public health initiatives aimed at developing evidence-based policies, interventions, and harm reduction strategies to address the challenges posed by cannabis legalization, substance abuse disorders, and drug-related harms.

4. Conclusion: The Significance of THC Measurement in IVD

In conclusion, the measurement of Tetrahydrocannabinol holds immense significance in the domain of in vitro diagnosis, encompassing a diverse array of applications spanning clinical, forensic, workplace, research, and public health realms. By leveraging advanced methodologies, innovative technologies, and specialized reagents, our company is committed to advancing the field of THC measurement, empowering healthcare professionals, law enforcement agencies, employers, researchers, and policymakers with the tools and insights needed to address the complex challenges posed by cannabis use and abuse. Through meticulous research, collaboration, and dedication to scientific excellence, we strive to enhance the accuracy, reliability, and accessibility of THC measurement solutions, thereby facilitating informed decision-making and promoting the health, safety, and well-being of individuals and communities worldwide.

About GDU